Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019
This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-06-04 | IntroReferral | Read twice and referred to the Committee on Finance. | Senate |
| 2019-06-04 | IntroReferral | Introduced in Senate | Library of Congress |